Stem cell transplant from a sibling or cousin donor
Part of Blood & lymphatic, Cancer clinical trials.
This study compares outcomes in patients receiving stem cell transplants from either a sibling or a cousin donor. It looks at the transplant process to help doctors understand which type of donor might lead to better results for people with blood cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older) diagnosed with a blood cancer, such as leukemia, lymphoma, or a related marrow disorder.
- You must be planning to receive your first stem cell transplant (no prior transplants).
- Your donor must be a sibling or a cousin (not a parent or child).
- The age difference between you and your donor must be 18 years or less.
- Your transplant must have happened between 2017 and 2024, and your medical records must show the exact transplant date.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of stem cell transplants for adults with T-ALL: one using a half-matched donor alone, and one using a half-matched donor plus umbilical cord blood. The goal is to see which approach gives better results with fewer side effects.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This trial tests a transplant using stem cells from an unrelated donor who is not a perfect match for your tissue type. It may be an option for people with blood cancers who can't find a fully matched related donor and need a transplant quickly.
This study looks at whether getting stem cells from a younger donor works better than from an older donor for people having their first stem cell transplant to treat blood cancer.
This study looks at using stem cells from a donor's bone marrow or blood to treat blood cancers like leukemia or lymphoma. It compares transplants from partially matched donors with fully matched donors to see how well they work.
This study is a registry that tracks outcomes for adults with blood diseases (such as leukemia, lymphoma, or severe aplastic anemia) who receive a haploidentical stem cell transplant—a transplant from a half-matched donor. The goal is to gather real-world data to understand how well this approach works for people who do not have a fully matched donor.
Hear when a new Haploidentical Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.